Hikma Lines Up US Hybrid Injectable

Deal With Arecor For Undisclosed Drug

 
• By Aidan Fry
  
Vaccine_Vial
Hikma is working with Arecor to develop a ready-to-use injectable for the US market • Source: Shutterstock

More from Deals

More from Business